The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancerDaniel Hormaechea‐Agulla, Raúl M. Luque, Michael D. Culler et al.|The FASEB Journal|2017Cited by 52
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea‐Agulla, Raúl M. Luque, Manuel D. Gahete et al.|Molecular Cancer|2017Cited by 51
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarkerDaniel Hormaechea‐Agulla, Raúl M. Luque, Enrique Gómez‐Gómez et al.|Cancer Letters|2016Cited by 38
275 In1-ghrelin splicing variant is over-expressed in prostate cancer where it increases aggressiveness featuresDaniel Hormaechea‐Agulla, Raúl M. Luque, Manuel D. Gahete et al.|European Urology Supplements|2015Cited by 1
Additional file 1: of The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea‐Agulla, Raúl M. Luque, Manuel D. Gahete et al.|Figshare|2017Cited by 0